Marika Murto brings over 20 years of pharmaceutical expertise in product strategy, innovation, and business transformationHer ...

The outpatient clinics market is projected to expand at a compound annual growth rate (CAGR) of 8% over the forecast period.

Continued Investment in Pipeline and Acquired Assets in 2026 to Fuel Long-Term GrowthReaffirms Full-Year 2025 Adjusted(1) Diluted EPS Guidance(2) and Revises Full-Year 2025 Revenue Guidance(2) to ...

The "Biocompatibility Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior executives in healthcare face evolving challenges as ...

Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials BOSTON, Dec.16, 2025 – Lindus Health, the "anti-CRO" running radically faster, more ...

SAS predicts the path for data and AI to reshape how the industry discovers, treats and delivers careMarlow, UK (December 16, 2025) – As we step into 2026, the AI and analytics story for health care ...

Global life sciences supply chain conference LogiPharma has announced a brand-new series of interactive formats for 2026 under the leadership of incoming event director, Ben Sharples.“This year’s ...

PARIS, FRANCE / ACCESS Newswire / December 16, 2025 / One year after deploying CaloPix®, the digital pathology platform developed by Tribun Health, NOVO Hospital (Val-d'Oise, France) reports clear, ...

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of a Phase II clinical trial ...

GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...

CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr.

Today, Latent Labs announces Latent-X2, a frontier AI model that can design drug-like biologics without iteration. Drug hunters can use Latent Lab's AI platform, built on Latent-X2, to access ...